| KKR Credit Income Fund (KKC) ORDINARY UNITS FULLY PAID |
Financials |
$774 |
Net Tangible Asset Backing
|
21 Jul 2025 9:21AM |
$2.380 |
$2.400 |
risen by
0.84%
|
|
| AKORA Resources Limited (AKO) ORDINARY FULLY PAID |
Materials |
$14 |
Noosa Presentation - Corporate Update
|
21 Jul 2025 9:21AM |
$0.115 |
$0.095 |
fallen by
17.39%
|
|
| Elsight Limited (ELS) ORDINARY FULLY PAID |
Information Technology |
$371 |
Quarterly Activity Report and Appendix 4C
|
21 Jul 2025 9:20AM |
$1.925 |
$1.700 |
fallen by
11.69%
|
|
ELS - Price-sensitive ASX Announcement
Full Release
Key Points
- Elsight reported positive operational cashflows during the quarter.
- Strong customer traction in the US drone market was noted.
- Recurring revenues from the Halo platform continued to grow.
- Expanded pilot and production deployments with new and existing clients.
- Key regulatory milestones achieved, supporting commercial scale-up.
- Announcements of new product certifications and integrations.
- Significant partnerships established and expanded in the autonomous vehicle sector.
- Prudent cost management practices contributed to positive financial performance.
- Solid cash position maintained to fund future growth initiatives.
- Focus remains on scaling operations, strategic partnerships, and revenue growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coppermoly Limited (COY) ORDINARY FULLY PAID |
Materials |
$12 |
Drilling Commenced at Fox Tail in EPM 27835
|
21 Jul 2025 9:20AM |
$0.011 |
$0.014 |
risen by
27.27%
|
|
| AnteoTech Limited (ADO) ORDINARY FULLY PAID |
Materials |
$65 |
Agreement for combined Anteo X product in the USA
|
21 Jul 2025 9:20AM |
$0.013 |
$0.024 |
risen by
84.62%
|
|
ADO - Price-sensitive ASX Announcement
Full Release
Key Points
- AnteoTech Limited has entered into a distribution agreement with ADO for Anteo X in the USA.
- ADO receives exclusive rights for Anteo X distribution in certain market segments and to specified customers.
- Anteo X is a newly developed product by AnteoTech targeting the US market.
- The agreement outlines terms, responsibilities, and exclusivity clauses.
- The partnership aims to accelerate Anteo X market adoption and revenue growth in the United States.
- Details provided on commercial structure and anticipated sales strategy.
- The collaboration is expected to enhance AnteoTech’s US market presence.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amaero Ltd (3DA) ORDINARY FULLY PAID |
Industrials |
$360 |
Quarterly Activities Report and Appendix 4C
|
21 Jul 2025 9:19AM |
$0.445 |
$0.390 |
fallen by
12.36%
|
|
3DA - Price-sensitive ASX Announcement
Full Release
Key Points
- Amaero advanced the construction and equipment procurement for its titanium powder manufacturing facility in Tennessee.
- Discussions with potential customers and partners for offtake agreements and collaborations are ongoing.
- Product qualification, regulatory approvals, and operational preparedness were key focus areas for the quarter.
- The company reported operational and capital investment-related cash outflows in the period.
- Amaero maintained sufficient cash reserves at the end of the quarter.
- The Appendix 4C contains a detailed breakdown of cash flows for operating, investing, and financing activities.
- Amaero’s strategic objectives include completing facility construction, securing customer agreements, and preparing for production commencement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bio-Gene Technology Ltd (BGT) ORDINARY FULLY PAID |
Materials |
$6 |
Change of Director's Interest Notice PM
|
21 Jul 2025 9:19AM |
$0.018 |
$0.021 |
risen by
16.67%
|
|
| Dundas Minerals Limited (DUN) ORDINARY FULLY PAID |
Materials |
$2 |
TMB: Tambourah Drilling Update RC Program Extended
|
21 Jul 2025 9:18AM |
$0.019 |
$0.020 |
risen by
5.26%
|
|
| Tambourah Metals Ltd (TMB) ORDINARY FULLY PAID |
Materials |
$8 |
Tambourah Drilling Update RC Program Extended
|
21 Jul 2025 9:18AM |
$0.022 |
$0.047 |
risen by
113.64%
|
|
| Beacon Minerals Limited (BCN) ORDINARY FULLY PAID |
Materials |
$229 |
Notification of buy-back - BCN
|
21 Jul 2025 9:17AM |
$1.205 |
$2.170 |
risen by
80.08%
|
|
| Beacon Minerals Limited (BCN) ORDINARY FULLY PAID |
Materials |
$229 |
Beacon Announces On Market Share Buy-Back
|
21 Jul 2025 9:17AM |
$1.205 |
$2.170 |
risen by
80.08%
|
|
BCN - Price-sensitive ASX Announcement
Full Release
Key Points
- Beacon Minerals Limited announced an on-market share buy-back.
- Up to 10% of shares may be purchased over a 12-month period.
- The buy-back aims to improve capital efficiency and deliver shareholder value.
- The Board believes the share price undervalues the company’s assets and prospects.
- Funding will come from existing cash reserves.
- Buy-back execution depends on market conditions and share price.
- The Board retains discretion over the number of shares bought back.
- The buy-back will comply with ASX Listing Rules and the Corporations Act.
- No guarantee that the entire 10% will be purchased.
- There will be no effect on company control or ASX listing.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IperionX Limited (IPX) ORDINARY FULLY PAID |
Materials |
$2,334 |
Trading Halt
|
21 Jul 2025 9:17AM |
$5.300 |
$6.990 |
risen by
31.89%
|
|
IPX - Price-sensitive ASX Announcement
Full Release
Key Points
- IperionX Limited requests trading halt on 21 July 2025.
- The trading halt is due to a proposed capital raising.
- The halt will last until the announcement or 23 July 2025.
- Request made in accordance with ASX Listing Rule 17.1.
- IperionX Limited is unaware of reasons against the halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IperionX Limited (IPX) ORDINARY FULLY PAID |
Materials |
$2,334 |
Trading Halt
|
21 Jul 2025 9:17AM |
$5.300 |
$6.990 |
risen by
31.89%
|
|
IPX - Price-sensitive ASX Announcement
Full Release
Key Points
- IperionX Limited requested a trading halt on its securities.
- The halt is pending an announcement regarding a proposed capital raising.
- The trading halt is expected to last until an announcement is made or trading commences on 23 July 2025.
- IperionX Limited is listed on the ASX under the code IPX.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bio-Gene Technology Ltd (BGT) ORDINARY FULLY PAID |
Materials |
$6 |
Change of Director's Interest Notice TG
|
21 Jul 2025 9:17AM |
$0.018 |
$0.021 |
risen by
16.67%
|
|
| Antares Metals Limited (AM5) ORDINARY FULLY PAID |
Materials |
$4 |
Extensional Targets Confirmed by Assays at Surprise
|
21 Jul 2025 9:16AM |
$0.008 |
$0.008 |
fallen by
0%
|
|
AM5 - Price-sensitive ASX Announcement
Full Release
Key Points
- Confirmation of extensional gold targets at the Surprise prospect within the Mandilla Gold Project.
- Assay results demonstrate high-grade gold mineralisation beyond existing resource boundaries.
- Drilling expanded the known mineralisation footprint both laterally and at depth.
- Significant gold intercepts reported from recent reverse circulation and diamond drilling programs.
- Results support the potential for future resource growth at Surprise.
- Antares Metals will continue systematic drilling to further define new extensional zones.
- Assay results to be incorporated into upcoming resource updates.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PM Capital Global Opportunities Fund Limited (PGF) ORDINARY FULLY PAID |
Financials |
$1,342 |
Net Tangible Asset Backing - 18 July 2025
|
21 Jul 2025 9:16AM |
$2.620 |
$2.800 |
risen by
6.87%
|
|
| Renegade Exploration Limited (RNX) ORDINARY FULLY PAID |
Materials |
$6 |
Proposed issue of securities - RNX
|
21 Jul 2025 9:16AM |
$0.004 |
$0.004 |
fallen by
12.50%
|
|
| Renegade Exploration Limited (RNX) ORDINARY FULLY PAID |
Materials |
$6 |
Equity Raising of up to $2,290,000
|
21 Jul 2025 9:16AM |
$0.004 |
$0.004 |
fallen by
12.50%
|
|
RNX - Price-sensitive ASX Announcement
Full Release
Key Points
- Renegade Exploration Limited (RNX) is undertaking an equity raising of up to $2,290,000.
- The raising is via a non-renounceable pro-rata entitlement offer to eligible shareholders.
- Shareholders are offered new shares at a specified issue price, details of which are outlined in the document.
- Funds raised will be used primarily for exploration activities and general working capital.
- The Board believes the capital raising is essential for ongoing operations and future growth.
- Risks and benefits of the entitlement offer are discussed for potential participants.
- Timetable for the offer, including opening and closing dates, is provided.
- Eligibility criteria for shareholders and application instructions are detailed.
- Directors’ support and intentions regarding the offer are disclosed.
- The document emphasizes the importance of reading the entire offer booklet before making investment decisions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$365 |
Update - Notification of buy-back - PE1
|
21 Jul 2025 9:15AM |
$1.250 |
$1.325 |
risen by
6%
|
|
| Eclipse Metals Ltd (EPM) ORDINARY FULLY PAID |
Energy |
$90 |
Investor Presentation
|
21 Jul 2025 9:15AM |
$0.019 |
$0.030 |
risen by
57.89%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$83 |
Trading Halt
|
21 Jul 2025 9:13AM |
$0.285 |
$0.165 |
fallen by
42.11%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by Amplia Therapeutics Limited (ASX: ATX) effective 5 June 2024.
- The trading halt is in relation to a proposed capital raising.
- The halt will remain in place until an announcement is made or trading commences on 7 June 2024.
- Company has confirmed there are no reasons the trading halt should not be granted.
- No additional information required to inform the market at the time of request.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RBR Group Limited (RBR) ORDINARY FULLY PAID |
Materials |
$3 |
RBR Positions for Mozambique LNG Growth
|
21 Jul 2025 9:13AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
RBR - Price-sensitive ASX Announcement
Full Release
Key Points
- RBR Group Limited is positioning itself as a workforce solutions provider for Mozambique's LNG projects.
- The company has developed capabilities in recruitment, training, and compliance to meet local content requirements.
- RBR is engaging with international and local contractors involved in the LNG projects.
- The firm has established an operational presence in Mozambique with required licenses and partnerships.
- Services are tailored to support delivery of large, compliant workforces for LNG construction and operations.
- RBR expects multi-year revenue growth opportunities from Mozambique’s LNG sector.
- The company’s strategy focuses on being a trusted partner in workforce management for the region’s LNG industry.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BKI Investment Company Limited (BKI) ORDINARY FULLY PAID |
Financials |
$1,453 |
BKI Investor Presentation - 2025 Full Year Results
|
21 Jul 2025 9:12AM |
$1.795 |
$1.800 |
risen by
0.28%
|
|
BKI - Price-sensitive ASX Announcement
Full Release
Key Points
- BKI delivered another year of positive investment returns and upheld its dividend policy.
- The portfolio is concentrated in high-quality Australian listed companies with a bias towards income-producing stocks.
- The company maintained a low-cost structure and continued disciplined, long-term investment strategies.
- BKI outperformed relevant indices over several timeframes, reinforcing its track record.
- Dividend growth was maintained, reflecting resilience and the company’s income focus.
- The management team actively managed capital and took a cautious approach amid market volatility.
- Risk management and governance remain core priorities for the Board and management.
- Sector allocations and top ten holdings are regularly reviewed to ensure alignment with strategy.
- The outlook for the next financial year is cautiously optimistic, emphasizing income and capital preservation for shareholders.
- BKI remains committed to providing shareholders with a stable income stream backed by a high-quality, diversified portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RareX Limited (REE) ORDINARY FULLY PAID |
Materials |
$20 |
Proposed issue of securities - REE
|
21 Jul 2025 9:11AM |
$0.027 |
$0.020 |
fallen by
27.78%
|
|
| RareX Limited (REE) ORDINARY FULLY PAID |
Materials |
$20 |
Proposed issue of securities - REE
|
21 Jul 2025 9:11AM |
$0.027 |
$0.020 |
fallen by
27.78%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
